Hormonal Changes After Roux-en Υ Gastric Bypass For Morbid Obesity and the Control of Type-II Diabetes Mellitus

Clements, Ronald H.; Gonzalez, Quintin H.; Long, Calvin I.; Wittert, Gary; Laws, Henry L.
January 2004
American Surgeon;Jan2004, Vol. 70 Issue 1, p1
Academic Journal
Morbid obesity (MO) is associated with diabetes mellitus-type II (DM-II). Roux-en Y gastric bypass (RNY) has been shown to normalize glucose intolerance in these patients through an incompletely understood mechanism. Gastrointestinal hormonal changes have been suggested as an explanation for resolution of DM II. Preoperatively, 20 MO patients with DM-II were evaluated for demographics and fasting levels of the following: glucose, insulin, C-peptide, glucagon, cortisol, gastric inhibitory polypeptide (GIP), and glucagon-like peptide-1 (GLP-1). Each patient underwent RNY with a 15-cc gastric pouch and 150-cm Roux limb. Postoperatively, each of the variables was measured at 2 Weeks, 6 weeks, and 12 weeks and compared with the preoperative result using Student t test with significance, P = 0.05. Results are expressed as mean ± SD. Twenty patients (5 male and 15 female), age 40.3 ± 7.9 years, weight 146.3 ± 34.0 kg, height 158.7 ± 18.7 cm, and BMI 52.7 ± 8.8, were enrolled in this IRB-approved protocol. Weight and BMI decreased progressively (117.5 ± 26.9 kg and 47.0 ± 7.4, P = 0.01, respectively) during the study but reached significance only at 12 weeks. Fasting plasma glucose decreased significantly within 2 weeks after RNY. Insulin and cortisol both approached, but never achieved, significant changes over 12 weeks. GLP-1 increased initially, but not significantly. GIP and C-peptide both decreased significantly. Glucagon remained essentially unchanged over 12 weeks. RNY rapidly normalizes fasting plasma glucose in morbidly obese patients with DM-II. GIP, a gactor in the enteroinsulin axis, decreases and may play a role in the correction of DM-II after gastric bypass.


Related Articles

  • Roux-en-Y Gastric Bypass-Induced Improvement of Glucose Tolerance and Insulin Resistance in Type 2 Diabetic Rats Are Mediated by Glucagon-Like Peptide-1. Liu, Yuan; Zhou, Yong; Wang, Yong; Geng, Donghua; Liu, Jingang // Obesity Surgery;Sep2011, Vol. 21 Issue 9, p1424 

    Background: The aim of this study was to investigate the effects of Roux-en-Y gastric bypass (RYGB) on glucose tolerance and insulin resistance in type 2 diabetic rats and the possible mechanisms involved in this process. Methods: Thirty Goto-Kakizaki (GK) rats were randomly divided into three...

  • BY THE NUMBERS.  // Endocrine Today;Apr2014, Vol. 12 Issue 4, p1 

    A chart is presented that indicates the role of bariatric surgery, or gastric bypass, in controlling diabetes, published in the "New England Journal of Medicine."

  • Ileal Interposition in Rats with Experimental Type 2 Like Diabetes Improves Glycemic Control Independently of Glucose Absorption. Jurowich, Christian Ferdinand; Otto, Christoph; Rikkala, Prashanth Reddy; Wagner, Nicole; Vrhovac, Ivana; Sabolić, Ivan; Germer, Christoph-Thomas; Koepsell, Hermann // Journal of Diabetes Research;6/22/2015, Vol. 2015, p1 

    Bariatric operations in obese patients with type 2 diabetes often improve diabetes before weight loss is observed. In patients mainly Roux-en-Y-gastric bypass with partial stomach resection is performed. Duodenojejunal bypass (DJB) and ileal interposition (IIP) are employed in animal...

  • Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass. Han, Haifeng; Wang, Lei; Du, Hao; Jiang, Jianjun; Hu, Chunxiao; Zhang, Guangyong; Liu, Shaozhuang; Zhang, Xiang; Liu, Teng; Hu, Sanyuan // Obesity Surgery;Oct2015, Vol. 25 Issue 10, p1802 

    Background: Serum bile acids (BAs) are elevated after metabolic surgeries including Roux-en-Y gastric bypass (RYGB), ileal transposition (IT), and duodenal-jejunal bypass (DJB). Recently, BAs have emerged as a kind of signaling molecules, which can not only promote glucagon-like peptide-1...

  • Comparison of Glucostatic Parameters After Hypocaloric Diet or Bariatric Surgery and Equivalent Weight Loss. Plum, Leona; Ahmed, Leaque; Febres, Gerardo; Bessler, Marc; Inabnet, William; Kunreuther, Elizabeth; McMahon, Donald J.; Korner, Judith // Obesity (19307381);Nov2011, Vol. 19 Issue 11, p2149 

    Weight-loss independent mechanisms may play an important role in the improvement of glucose homeostasis after Roux-en-Y gastric bypass (RYGB). The objective of this analysis was to determine whether RYGB causes greater improvement in glucostatic parameters as compared with laparoscopic...

  • Influence of diabetes surgery on a gut-brain-liver axis regulating food intake and internal glucose production. Mithieux, G. // Nutricion Hospitalaria;mar/abr suplemento 2, Vol. 28, p104 

    It has long been known that the brain, especially the hypothalamus, can modulate both insulin secretion and hepatic glucose fluxes, via the modulation of the sympathetic system (promoting glycogen breakdown) and the parasympathetic system (stimulating glycogen deposition). Central insulin...

  • Specific Effects of Biliopancreatic Diversion on the Major Components of Metabolic Syndrome. Scopinaro, Nicola; Marinari, Giuseppe Maria; Camerini, Giovanni Bruno; Papadia, Francesco Saverio; Adami, Gian Franco // Diabetes Care;Oct2005, Vol. 28 Issue 10, p2406 

    OBJECTIVE -- Gastric bypass and biliopancreatic diversion (BPD) are known to have a beneficial effect on glucose metabolism superior to that of the other bariatric operations. Thanks to its excellent weight loss results and to its specific actions, BPD has proven able to guarantee permanent...

  • Association of Ghrelin Receptor Promoter Polymorphisms with Weight Loss Following Roux-en-Y Gastric Bypass Surgery. Matzko, Michelle; Argyropoulos, George; Wood, G.; Chu, Xin; McCarter, Roger; Still, Christopher; Gerhard, Glenn // Obesity Surgery;May2012, Vol. 22 Issue 5, p783 

    Background: Ghrelin plays a role in appetite and has been hypothesized to play a role in the mechanism of Roux-en-Y gastric bypass (RYGB) surgery. Single nucleotide polymorphisms (SNPs) in the promoter region of its receptor gene (growth hormone secretagogue receptor type 1a-GHSR) have also been...

  • Plasma Glucose and Insulin Regulation Is Abnormal Following Gastric Bypass Surgery with or Without Neuroglycopenia. Kim, Sun H.; Liu, Teresa C.; Abbasi, Fahim; Lamendola, Cindy; Morton, John M.; Reaven, Gerald M.; McLaughlin, Tracey L. // Obesity Surgery;Nov2009, Vol. 19 Issue 11, p1550 

    The article discusses research on whether or not plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopenia. The study compared plasma glucose and insulin responses to oral glucose in individuals with symptomatic hypoglycemia versus...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics